Camenisch G - Search Results

1

Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat.

Umehara K, Camenisch G. Umehara K, et al. Among authors: camenisch g. Pharm Res. 2012 Feb;29(2):603-17. doi: 10.1007/s11095-011-0607-2. Epub 2011 Oct 20. Pharm Res. 2012. PMID: 22011931

2

Review of theoretical passive drug absorption models: historical background, recent developments and limitations.

Camenisch G, Folkers G, van de Waterbeemd H. Camenisch G, et al. Pharm Acta Helv. 1996 Nov;71(5):309-27. doi: 10.1016/s0031-6865(96)00031-3. Pharm Acta Helv. 1996. PMID: 8973162 Review.

3

A comparison of the bioconversion rates and the Caco-2 cell permeation characteristics of coumarin-based cyclic prodrugs and methylester-based linear prodrugs of RGD peptidomimetics.

Camenisch GP, Wang W, Wang B, Borchardt RT. Camenisch GP, et al. Pharm Res. 1998 Aug;15(8):1174-81. doi: 10.1023/a:1011975404789. Pharm Res. 1998. PMID: 9706046

4

Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight.

Camenisch G, Alsenz J, van de Waterbeemd H, Folkers G. Camenisch G, et al. Eur J Pharm Sci. 1998 Oct;6(4):317-24. Eur J Pharm Sci. 1998. PMID: 9795088

5

Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway.

Camenisch G, Folkers G, van de Waterbeemd H. Camenisch G, et al. Eur J Pharm Sci. 1998 Oct;6(4):325-29. Eur J Pharm Sci. 1998. PMID: 9795090

6

The outstanding metabolic stability of a 14C-labeled beta-nonapeptide in rats--in vitro and in vivo pharmacokinetic studies.

Wiegand H, Wirz B, Schweitzer A, Camenisch GP, Rodriguez Perez MI, Gross G, Woessner R, Voges R, Arvidsson PI, Frackenpohl J, Seebach D. Wiegand H, et al. Among authors: camenisch gp. Biopharm Drug Dispos. 2002 Sep;23(6):251-62. doi: 10.1002/bdd.334. Biopharm Drug Dispos. 2002. PMID: 12214326

7

Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions.

Camenisch G, Umehara K. Camenisch G, et al. Biopharm Drug Dispos. 2012 May;33(4):179-94. doi: 10.1002/bdd.1784. Epub 2012 Apr 19. Biopharm Drug Dispos. 2012. PMID: 22407504

8

Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters.

Kunze A, Huwyler J, Camenisch G, Gutmann H. Kunze A, et al. Among authors: camenisch g. Biochem Pharmacol. 2012 Oct 15;84(8):1096-102. doi: 10.1016/j.bcp.2012.07.032. Epub 2012 Aug 4. Biochem Pharmacol. 2012. PMID: 22902721

9

In vitro-in vivo extrapolation method to predict human renal clearance of drugs.

Kunze A, Huwyler J, Poller B, Gutmann H, Camenisch G. Kunze A, et al. Among authors: camenisch g. J Pharm Sci. 2014 Mar;103(3):994-1001. doi: 10.1002/jps.23851. Epub 2014 Jan 13. J Pharm Sci. 2014. PMID: 24549735

10

Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.

Kunze A, Huwyler J, Camenisch G, Poller B. Kunze A, et al. Among authors: camenisch g. Drug Metab Dispos. 2014 Sep;42(9):1514-21. doi: 10.1124/dmd.114.058412. Epub 2014 Jul 2. Drug Metab Dispos. 2014. PMID: 24989890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results